STOCK TITAN

Apollo Biowellness, Inc. Announces Joint Venture/Partnership with Reveal Lasers LLC for Expanded Distribution and Collaboration of Evo Bio Products.

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership

Apollo Biowellness (OTC Pink: KOAN) has announced a joint venture with Reveal Lasers to expand distribution of Evolutionary Biologics' products in the aesthetic and regenerative health market. The partnership will enable distribution of biologic products through Reveal Lasers' channels across the US, Europe, Middle East, and Canada. Evolutionary Biologics, operating from an ISO5 GMP-certified FDA laboratory, will soon introduce PRP and PRF products to complement its existing portfolio. The collaboration aims to integrate biologic products with Reveal Lasers' technology for enhanced treatment protocols.

Apollo Biowellness (OTC Pink: KOAN) ha annunciato una joint venture con Reveal Lasers per ampliare la distribuzione dei prodotti di Evolutionary Biologics nel mercato della salute estetica e rigenerativa. La partnership consentirà la distribuzione di prodotti biologici attraverso i canali di Reveal Lasers negli Stati Uniti, in Europa, Medio Oriente e Canada. Evolutionary Biologics, che opera da un laboratorio certificato ISO5 GMP dalla FDA, introdurrà presto prodotti PRP e PRF per completare il suo portafoglio esistente. La collaborazione mira a integrare i prodotti biologici con la tecnologia di Reveal Lasers per protocolli di trattamento migliorati.

Apollo Biowellness (OTC Pink: KOAN) ha anunciado una empresa conjunta con Reveal Lasers para expandir la distribución de los productos de Evolutionary Biologics en el mercado de salud estética y regenerativa. La asociación permitirá la distribución de productos biológicos a través de los canales de Reveal Lasers en los EE. UU., Europa, Medio Oriente y Canadá. Evolutionary Biologics, que opera desde un laboratorio certificado por la FDA ISO5 GMP, pronto introducirá productos PRP y PRF para complementar su cartera existente. La colaboración tiene como objetivo integrar los productos biológicos con la tecnología de Reveal Lasers para mejorar los protocolos de tratamiento.

아폴로 바이오웰니스 (OTC Pink: KOAN)는 리빌 레이저스와의 합작 투자를 발표하여 진화 생물학(Evolutionary Biologics)의 제품을 미용 및 재생 건강 시장에서 유통할 계획입니다. 이번 파트너십을 통해 리빌 레이저스의 유통 채널을 통해 미국, 유럽, 중동 및 캐나다에 생물학적 제품을 유통할 수 있게 됩니다. 진화 생물학은 FDA 인증을 받은 ISO5 GMP 실험실에서 운영되며, 기존 포트폴리오를 보완하는 PRP 및 PRF 제품을 곧 출시할 예정입니다. 이 협력은 치료 프로토콜을 향상시키기 위해 생물학적 제품과 리빌 레이저스의 기술을 통합하는 것을 목표로 합니다.

Apollo Biowellness (OTC Pink: KOAN) a annoncé un partenariat avec Reveal Lasers pour étendre la distribution des produits d'Evolutionary Biologics sur le marché de la santé esthétique et régénérative. Ce partenariat permettra la distribution de produits biologiques par le biais des canaux de Reveal Lasers à travers les États-Unis, l'Europe, le Moyen-Orient et le Canada. Evolutionary Biologics, opérant depuis un laboratoire certifié ISO5 GMP par la FDA, introduira bientôt des produits PRP et PRF pour compléter son portefeuille existant. La collaboration vise à intégrer les produits biologiques avec la technologie de Reveal Lasers pour améliorer les protocoles de traitement.

Apollo Biowellness (OTC Pink: KOAN) hat ein Joint Venture mit Reveal Lasers angekündigt, um die Verbreitung der Produkte von Evolutionary Biologics im Bereich der ästhetischen und regenerativen Gesundheit zu erweitern. Die Partnerschaft wird die Verteilung biologischer Produkte über die Kanäle von Reveal Lasers in den USA, Europa, dem Nahen Osten und Kanada ermöglichen. Evolutionary Biologics, das in einem ISO5 GMP-zertifizierten FDA-Labor operiert, wird bald PRP- und PRF-Produkte einführen, um sein bestehendes Portfolio zu ergänzen. Die Zusammenarbeit zielt darauf ab, biologische Produkte mit der Technologie von Reveal Lasers für verbesserte Behandlungsprotokolle zu integrieren.

Positive
  • Expanded international distribution network across US, Europe, Middle East, and Canada
  • Integration with Reveal Lasers' existing sales infrastructure
  • Product line expansion with upcoming PRP and PRF products
  • Access to established distribution channels in aesthetic and regenerative markets
Negative
  • None.

North Bergen, New Jersey--(Newsfile Corp. - October 31, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) is pleased to announce a joint venture and distribution partnership with Reveal Lasers LLC to expand the reach of Evolutionary Biologics, Inc.'s biologic products across the aesthetic and regenerative health market. This collaboration will position Evolutionary Biologics' premium biologic solutions within Reveal Lasers' extensive distribution channels, allowing Plastic Surgeons, Dermatologists, and Medical Spas worldwide access to industry-leading products for pre- and post-surgical care, anti-aging, and regenerative treatments.

Evolutionary Biologics' biologics, produced in their ISO5 GMP-certified FDA laboratory, have been developed with proven efficacy and are currently distributed through a robust network of medical professionals. This partnership enables Reveal Lasers to distribute Evolutionary Biologics products not only in the United States but also in Europe, the Middle East, and Canada. Reveal Lasers' strong commercial sales infrastructure and expertise will amplify Evolutionary's market reach, offering international distribution that extends beyond current capabilities.

"With this partnership, we're combining two innovative portfolios to provide a more integrated, powerful solution for aesthetic and regenerative medicine providers worldwide," said Jim Morrison, CEO/President of Apollo Biowellness, Inc. and Evolutionary Biologics, Inc. "The combination of Evolutionary Biologics and Reveal Lasers' technology opens new pathways for treatment protocols that elevate patient outcomes and support practitioners at every level."

Reveal Lasers will incorporate Evolutionary Biologics products into new procedural protocols that utilize their aesthetic and regenerative laser technologies, expanding the versatility and application of each treatment for providers. This integration will further strengthen Reveal Lasers' position as a leader in comprehensive aesthetic solutions.

"Our collaboration with Apollo Biowellness is transformative, allowing us to expand our portfolio and provide providers with a total solution for patient care," stated Bob Daley, CEO of Reveal Lasers LLC. "By combining advanced laser technology with biologic and regenerative products, we're paving the way for a holistic approach that enhances both results and the patient experience."

In addition to the core biologics, Evolutionary Biologics will soon introduce PRP and PRF products to complement its existing portfolio. Widely used by clinicians and medical spas, these regenerative products will offer further support for aesthetic and surgical procedures, providing a fully integrated solution for Plastic Surgeons, Dermatologists, Med Spas, and Regenerative Clinics.

The partnership between Reveal Lasers LLC and Evolutionary Biologics marks a significant step toward a fully vertically integrated suite of protocols and solutions, driving substantial revenue growth and value creation for both companies.

About Apollo Biowellness, Inc. f/k/a Resonate Blends, Inc.
Apollo Biowellness, Inc., along with its subsidiary Evolutionary Biologics, Inc., is dedicated to advancing the field of regenerative medicine through innovative biologic-based solutions. As a leader in this space, Apollo focuses on the discovery, development, and marketing of products that promote wellness and enhance quality of life. Our efforts include licensed, patent-pending natural agents aimed at stimulating individuals' own stem cell mobilization from bone marrow, as well as a dual-acting, all-natural diet aid designed to support hunger control through natural body signals. With a commitment to both consumer and professional markets, Apollo Biowellness is at the forefront of developing and distributing products that shape the future of regenerative health.

About Reveal Lasers LLC
Reveal Lasers is a leading provider of advanced technologies in the energy-based aesthetics industry, dedicated to delivering groundbreaking solutions that empower professionals and transform patient experiences. With a commitment to innovation and excellence, Reveal Lasers is reshaping the landscape of aesthetic medicine. For more information, visit https://us.reveallasers.com.

Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect the Company's business, including the business of any of its subsidiaries, is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.

Corporate Contact
Jim Morrison
CEO/Director
jmorrison@evolutionarybiologics.com
www.emergenthealthcompany.com
203-253-9191

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228403

FAQ

What is the partnership between Apollo Biowellness (KOAN) and Reveal Lasers ?

Apollo Biowellness (KOAN) has formed a joint venture with Reveal Lasers to distribute Evolutionary Biologics' products through Reveal's channels across the US, Europe, Middle East, and Canada in the aesthetic and regenerative health market.

What new products will Evolutionary Biologics introduce through the Reveal Lasers partnership?

Evolutionary Biologics will introduce PRP and PRF products to complement its existing portfolio of biologic products for aesthetic and surgical procedures.

Where will Apollo Biowellness (KOAN) distribute its products through the Reveal Lasers partnership?

Through the partnership, Apollo Biowellness will distribute its products in the United States, Europe, the Middle East, and Canada via Reveal Lasers' distribution channels.

RESONATE BLENDS INC

OTC:KOAN

KOAN Rankings

KOAN Latest News

KOAN Stock Data

552.21k
88.12M
5.18%
7.05%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
North Bergen